Is CardioComm Solutions, Inc. (EKGGF) a Buy, Sell, or Hold?
OTC : EKGGF
CardioComm Solutions, Inc.
$0.0109 USD
$0 (0.0%)
- Volume
- 5K
- Average Volume
- 115
- Market Capitalization
- $2.15M
- P/E Ratio
- -5.66
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.01
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.17
Industry, Sector & symbol
| Stock Exchange | OTC |
| CEO | Etienne Grima |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Current Symbol | EKGGF |
| CUSIP | 14159N208 |
| CIK | None |
| Web | https://www.cardiocommsolutions.com |
| Phone | +1 416 977 9425 |
| Currency | USD |
| Employees | 16 |
| Country | CA |
Liquidity
| Debt-to-Equity Ratio | -1.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.17 |
| Quick Ratio | 0.15 |
| Cash Ratio | 0.07 |
Sales & Book Value
| Annual Sales | $271.94K |
| Price / Sales | 11.10 |
| Cash Flow | 0.00 |
| Price / Cash Flow | -6.63 |
| Price / Book | -4.38 |
Price Target and Rating
| Average Stock Price Forecast | |
| High Stock Price Forecast | |
| Low Stock Price Forecast | |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | -$0.0027 |
| Trailing P/E Ratio | -5.66 |
| PEG Ratio | 0.08 |
| P/E Growth | 0.08 |
| Net Income | -$529.06K |
| Net Margin | -186.94% |
| Pretax Margin | -186.94% |
| Return on Equity | 103.28% |
| Return on Assets | -328.37% |
Financials Score
| AltmanZ Score | -335.47 |
| Piotroski Score | 1.00 |
| Working Capital | -591.02K |
| Total Assets | 154.91K |
| Ebit | -467.38K |
| Market Cap | 3.05M |
| Total Liabilities | 843.77K |
Poll Results
About CardioComm Solutions, Inc. (OTC:EKGGF) Stock
CardioComm Solutions, Inc., established in 1989 and based in Toronto, Canada, specializes in developing advanced technological solutions for cardiac monitoring. The company delivers both sophisticated software and hardware products, as well as core laboratory reading services, specifically designed for electrocardiogram (ECG) and ambulatory arrhythmia detection systems. These comprehensive offerings cater to both the medical sector and individual consumers across the globe. At the heart of CardioComm's operations is proprietary technology that underpins the entire ECG workflow: from initial recording and seamless transmission to detailed viewing, in-depth analysis, comprehensive reporting, and secure long-term storage. This end-to-end capability is crucial for the effective screening, accu ... rate diagnosis, and ongoing management of cardiac patients. Their unique device connectivity and ECG management platforms are integrated into diverse solutions, spanning general medical applications, consumer-grade health products, clinical research initiatives, and modern telemedicine services. The company's extensive software suite includes the Global ECG Management System (GEMS) for cardiac event monitoring, GlobalCardio 12 Lead—a web-enabled and EMR-compatible ECG device—and GEMS Lite for Windows, an electronic system for receiving ECG data. Complementary software modules further enhance their offerings, such as GEMS WIN Air for live wireless ECG monitoring, AutoAttendant to empower healthcare providers by automating routine tasks, and the GEMS HL7 Interface, which ensures compliant data exchange with other EMR systems. Additionally, GlobalCardio EMR integration facilitates the bi-directional transfer of crucial information, including patient data, reports, and related links. Beyond software, CardioComm provides a range of hardware products. These include the portable HeartCheck PEN and HeartCheck handheld ECG monitors, various Sirona telephonic and wireless event recorders, and the HeartCheck CardiBeat device. Furthermore, the company offers Application Service Provider (ASP) solutions, notably C4 ECG management services and HeartCheck SMART Monitoring. Their broader product portfolio also features GlobalCardio 3 Lead, the ECG Viewer SDK, QRS Diagnostic, and QRS 12 Lead Universal.
CardioComm Solutions and Predictiv AI Enter into Strategic AI Collaboration
2026-06-08 09:11:00
Toronto, Ontario--(Newsfile Corp. - June 8, 2026) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a provider of consumer heart monitoring, remote patient monitoring and medical electrocardiogram ("ECG") software solutions, is pleased to announce that it has entered into a strategic collaboration, joint development and intellectual property agreement with Predictiv AI Inc. ("Predictiv AI") of North York, Ontario. The agreement establishes a framework under which the companies may identify, assess and, where mutually approved, pursue specific projects involving healthcare software, medical software, artificial intelligence, automated analytics, remote patient monitoring, clinical decision support, biosignal interpretation, predictive analytics, workflow optimization and software as a medical device applications.
2026-05-08 16:01:00
Toronto, Ontario--(Newsfile Corp. - May 8, 2026) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leader in consumer heart monitoring, remote patient monitoring, and medical electrocardiogram ("ECG") software solutions, announces that it has elected to rely on Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers and move to semi-annual financial reporting ("SAR"). Coordinated Blanket Order 51-933 allows eligible venture issuers listed on the TSX Venture Exchange (the "TSXV") to voluntarily move from a quarterly to a semi-annual financial reporting framework.
Frequently Asked Questions
-
What is the current CardioComm Solutions, Inc. (EKGGF) stock price?
-
CardioComm Solutions, Inc.(OTC:EKGGF) stock price is $0.0109 in the last trading session. During the trading session, EKGGF stock reached the peak price of $0.011 while $0.004 was the lowest point it dropped to. The percentage change in EKGGF stock occurred in the recent session was 0.0% while the dollar amount for the price change in EKGGF stock was $0.
-
EKGGF's industry and sector of operation?
-
The OTC listed EKGGF is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.
-
Who are the executives of EKGGF?
-
Branislav Vasilijevic | Director of Software Engineering
Etienne Grima | Chief Executive Officer, Corporate Secretary & Director
Robert E. Caines | Chairman & Chief Financial Officer
|
| -
How many employees does EKGGF have?
-
Number of EKGGF employees currently stands at 16. EKGGF operates from 18 Wynford Drive, Toronto, ON M3C 3S2, CA.
-
Link for EKGGF official website?
-
Official Website of EKGGF is: https://www.cardiocommsolutions.com
-
How do I contact EKGGF?
-
EKGGF could be contacted at phone #+1 416 977 9425 and can also be accessed through its website. EKGGF operates from 18 Wynford Drive, Toronto, ON M3C 3S2, CA.
-
How many shares of EKGGF are traded daily?
-
The average number of EKGGF shares traded daily for last 3 months was 115.
-
What is the market cap of EKGGF currently?
-
The market value of EKGGF currently stands at $2.15M with its latest stock price at $0.0109